@misc{10498/34460,
year = {2020},
url = {http://hdl.handle.net/10498/34460},
abstract = {Female anorgasmia, which the DSM-5 defines as a marked delay, marked
infrequency or absence of orgasm, occurs in the orgasm phase of sexual
response being the second most frequent sexual dysfunction in women.
It is widely accepted that drugs usage has devastating consequences on
sexual response. The aim of this study was to analyse the relationship
between drug use and anorgasmia and sexual satisfaction, and other
variables that can affect sexual response. An ex post facto study was
conducted. Two groups of women were selected through cluster sampling
from 28 drug rehabilitation centres belonging to the same institution
throughout Spain: drug-using females (n = 129) and non-drug-using
females (n = 129). They completed questionnaires about sexual function,
sexual satisfaction, anxiety and sexual attitudes. Female drug users presented
higher percentages of anorgasmia (13.18%>2.33%), sexual dissatisfaction
(34.10%>3.87%), sexual avoidance (47.28%>17.05%),
infrequency (59.68%>44.96%) and less erotic foreplay (3.10%>0.77%)
compared to the control group. Moreover, higher scores were obtained
in state anxiety (23.82 > 14.56) and trait anxiety (30.93 > 16.95), while
lower scores were obtained in erotophilia (84.93 < 95.81). Female drug
users reported significant impairments in sexual satisfaction, orgasm and
sexual attitudes, concurrently with greater infrequency, avoidance and
anxiety compared with the control group of non-drug-user females},
publisher = {Taylor and Francis},
keywords = {Anorgasmia; sexual attitudes; drug users; GRISS; ex post facto study},
keywords = {Anorgasmia},
keywords = {sexual attitudes},
keywords = {drug users},
keywords = {GRISS},
keywords = {ex post facto study},
title = {Consequences of drug use in female orgasm and sexual satisfaction in Spanish women},
doi = {10.1080/19419899.2020.1779117},
author = {Río Olvera, Francisco Javier del and Cabello-García, Marina A. and Cabello-Santamaría, Francisco},
}